240 related articles for article (PubMed ID: 7600129)
1. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E.
Clavey V; Lestavel-Delattre S; Copin C; Bard JM; Fruchart JC
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):963-71. PubMed ID: 7600129
[TBL] [Abstract][Full Text] [Related]
2. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
[TBL] [Abstract][Full Text] [Related]
3. [Interaction between LDL receptor and lipoproteins containing apo B].
Clavey V; Agnani G; Bard JM; Lestavel-Delattre S; Fruchart JC
Ann Endocrinol (Paris); 1991; 52(6):459-63. PubMed ID: 1824499
[TBL] [Abstract][Full Text] [Related]
4. [Effects of apolipoproteins AI, CI, CII, CIII and E on the binding of 125I-labeled apoE-deficient HDL3 to rat liver plasma membranes].
Zhang L; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):120-3. PubMed ID: 1664812
[TBL] [Abstract][Full Text] [Related]
5. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
Averna MR; Barbagallo CM; Di Paola G; Labisi M; Pinna G; Marino G; Dimita U; Notarbartolo A
Biol Neonate; 1991; 60(3-4):187-92. PubMed ID: 1797121
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
7. [Composition and distribution of lipid and apolipoprotein in plasma lipoproteins of endogenous hypertriglyceridemia].
Zhang L; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):117-21. PubMed ID: 1452137
[TBL] [Abstract][Full Text] [Related]
8. [The important role of apolipoprotein C-III in lipoprotein metabolism].
Fruchart JC; Duriez P
C R Seances Soc Biol Fil; 1995; 189(5):889-97. PubMed ID: 8673634
[TBL] [Abstract][Full Text] [Related]
9. Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study.
Gerber Y; Goldbourt U; Segev S; Harats D
Prev Med; 2003 Jul; 37(1):18-22. PubMed ID: 12799125
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
Murdoch SJ; Breckenridge WC
Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
[TBL] [Abstract][Full Text] [Related]
12. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
13. [Apolipoproteins AI, B100, CII, CIII and E in human cerebrospinal fluid].
Liu Y; Liu B; Yin J; Wu K; Wu L
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):352-4. PubMed ID: 1814810
[TBL] [Abstract][Full Text] [Related]
14. Abnormal concentrations of CII, CIII, and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients.
Alsayed N; Rebourcet R
Clin Chem; 1991 Mar; 37(3):387-93. PubMed ID: 2004445
[TBL] [Abstract][Full Text] [Related]
15. In vitro transfer of apolipoproteins from plasma lipoproteins to artificial lipid particles.
Asami H; Iriyama K
Nutrition; 1990; 6(2):143-5. PubMed ID: 2134526
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
[TBL] [Abstract][Full Text] [Related]
17. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
[TBL] [Abstract][Full Text] [Related]
18. Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII.
Rifai N; Silverman LM
Clin Chem; 1986 Oct; 32(10):1969-72. PubMed ID: 3093121
[TBL] [Abstract][Full Text] [Related]
19. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.
Reyes-Soffer G; Sztalryd C; Horenstein RB; Holleran S; Matveyenko A; Thomas T; Nandakumar R; Ngai C; Karmally W; Ginsberg HN; Ramakrishnan R; Pollin TI
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):63-72. PubMed ID: 30580564
[TBL] [Abstract][Full Text] [Related]
20. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
